June 23, 2017 11:38 PM ET


Company Overview of Cell-Medicine, Inc.

Company Overview

Cell-Medicine, Inc. manufactures, markets, and imports/exports pharmaceutical drugs for cancer. It offers autologous formalin-fixed tumor vaccine (AFTVac) that is injected to the patient from whom the cancerous tissue has been surgically resected. The company also conducts clinical trials to investigate the safety and feasibility of AFTVac on liver and brain cancer. Cell-Medicine, Inc. was founded in 2001 and is based in Tsukuba, Japan.

Sengen 2-1-6-C-B-1

Tsukuba,  305 0047


Founded in 2001


81 29 828 5591


81 29 828 5592

Key Executives for Cell-Medicine, Inc.

Chief Executive Officer and President
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
ABsize Inc. Asia
AccuRna, Inc. Asia
ACE Japan, L.L.C. Asia
Advanced Immunotherapy Co., Ltd. Asia
AETAS Pharma Co.,Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cell-Medicine, Inc., please visit www.cell-medicine.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.